Interestingly, it has been observed that some patients with GBM overexpress various chemokines and their receptors, such as CXCL10 (CXCR3) [20], CCL2 (CCR2) [21] and CCL11 (CCR3) [22]. This evidence concerns the gene CCL11 and glioblastoma.